Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cara Therapeutics (CARA)

  • Technical Exchange News
  • April 16, 2025, 00:57 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Cara Therapeutics, Inc. - Common Stock.

Comment Full text

Cara Therapeutics (CARA)

  • Technical Exchange News
  • April 16, 2025, 00:57 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Cara Therapeutics, Inc. - Common Stock. New value: Cara Therapeutics, Inc. - Common Stock.

Comment Full text

Cara Therapeutics (CARA)

  • Technical Exchange News
  • April 16, 2025, 00:57 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: D. New value: Cara Therapeutics, Inc. - Common Stock.

Comment Full text

Vincerx Pharma Inc. (VINC)

  • Technical Exchange News
  • April 16, 2025, 00:57 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Vincerx Pharma, Inc. - Common Stock.

Comment Full text

Mira Pharmaceuticals Inc (MIRA)

  • Technical Exchange News
  • April 15, 2025, 18:48 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Alaunos Therapeutics Inc (TCRT)

  • Technical Exchange News
  • April 15, 2025, 02:00 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Bone Biologics Corp (BBLG)

  • Technical Exchange News
  • April 15, 2025, 02:00 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Adicet Bio Inc (ACET)

  • Technical Exchange News
  • April 15, 2025, 02:00 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Alaunos Therapeutics Inc (TCRT)

  • Technical Exchange News
  • April 14, 2025, 19:07 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Bone Biologics Corp (BBLG)

  • Technical Exchange News
  • April 14, 2025, 19:06 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 203
  • 204
  • 205
  • 206
  • 207
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2261)
  • SEC News(189438)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124584)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin